Valuation : PAVmed Inc.

Market Cap 36.92M 31.79M 29.9M 27.32M 51.08M 3.49B 51.24M 353M 137M 1.79B 139M 136M 5.77B P/E 2026 *
-1.46x
P/E 2027 * -2.67x
Enterprise Value 36.92M 31.79M 29.9M 27.32M 51.08M 3.49B 51.24M 353M 137M 1.79B 139M 136M 5.77B EV / Sales 2026 *
159x
EV / Sales 2027 * 61.5x
Free-Float
58.56%
Yield 2026 *
-
Yield 2027 * -
1 day+3.73%
1 week+7.32%
Current month+1.34%
1 month+4.76%
3 months-3.12%
6 months-49.28%
Current year-20.29%
1 week 4.9
Extreme 4.9
5.65
1 month 4.19
Extreme 4.19
5.65
Current year 3.85
Extreme 3.85
28.44
1 year 3.85
Extreme 3.85
28.44
3 years 3.85
Extreme 3.85
270
5 years 3.85
Extreme 3.85
4,365
10 years 3.85
Extreme 3.85
6,502.5
Manager TitleAgeSince
Compliance Officer 62 2023-03-31
Chief Executive Officer 60 2014-06-25
Director of Finance/CFO 68 2019-02-28
Director TitleAgeSince
Director/Board Member 60 2014-09-30
Chairman 60 2014-06-25
Director/Board Member 71 2014-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
4/2/26 Free

Chief Technology Officer

70,000 1.0966%
4/2/26 Free

Chief Operating Officer

110,000 1.7233%
4/2/26 Free

Chief Executive Officer

350,000 5.4832%
Change 5-day change 1-year change 3-year change Capi.($)
+3.73%+7.32%-60.49%-97.10% 36.92M
-0.75%-1.35%+24.60%+13.24% 227B
-1.60%-3.89%+3.72%-20.39% 146B
-0.85%-1.58%-21.45%+19.18% 130B
+1.81%+2.05%-55.42%-10.32% 69.27B
+0.13%-0.34%+11.07%+18.34% 51.82B
+0.49%-1.32%-17.44%-13.87% 50.45B
+0.59%-1.94%+17.17%+27.06% 42.53B
-1.01%-1.28%+33.64%+48.14% 40.22B
-1.55%+1.22%+120.58%+36.88% 32.95B
Average +0.10%-0.68%+5.60%+2.12% 78.98B
Weighted average by Cap. -0.54%-1.55%+6.66%+8.04%

Financials

2026 *2027 *
Net sales 232K 200K 188K 172K 322K 21.97M 323K 2.22M 862K 11.25M 873K 854K 36.33M 600K 517K 486K 444K 830K 56.68M 833K 5.74M 2.23M 29.04M 2.25M 2.2M 93.75M
Net income -23.17M -19.96M -18.77M -17.15M -32.06M -2.19B -32.16M -222M -85.96M -1.12B -87.01M -85.11M -3.62B -20.15M -17.35M -16.32M -14.91M -27.87M -1.9B -27.96M -193M -74.74M -975M -75.65M -74M -3.15B
Net Debt - -
Logo PAVmed Inc.
PAVmed Inc. is a multi-product, commercial-stage medical technology company. The Company operates in the medical devices, diagnostics, and digital health sectors. Its subsidiary includes Lucid Diagnostics Inc., which is a commercial-stage cancer prevention medical diagnostics company that markets the EsoGuard Esophageal DNA Test and EsoCheck Esophageal Cell Collection Device for early detection of esophageal precancer to prevent esophageal cancer deaths. EsoCheck is a noninvasive swallowable balloon capsule catheter device capable of sampling surface esophageal cells. EsoGuard is a bisulfite-converted next-generation sequencing (NGS) DNA assay performed on surface esophageal cells collected with EsoCheck. Its other subsidiary, Veris Health Inc., is a digital health company focused on enhanced personalized cancer care through remote patient monitoring using implantable biologic sensors with wireless communication along with a custom suite of connected external devices.
Employees
41
Date Price Change Volume
26-09-04 US$5.280 +3.73% 66,489
26-09-03 US$5.090 -4.86% 5,746
26-09-02 US$5.350 +7.21% 7,002
26-09-01 US$4.990 -4.22% 4,211
26-08-31 US$5.210 +5.89% 31,436
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
5.280USD
Average target price
36.50USD
Spread / Average Target
+591.29%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. PAVM Stock